StocksHealthcareABT

ABT

ABBOTT LABORATORIES
NYSEResearch view
Healthcare · Pharmaceutical Preparations · Large-cap · SEC EDGAR FY 2025-12-31

Price history

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2025-12-31
SectorHealthcare
Market Cap$177.1B
Enterprise Value$184.6B
Income$6.5B
Sales$44.3B
Book/sh$30.30
Cash/sh$4.89
Dividend TTM$2.40
Payout63%
Employees
IPO
Quick Ratio1.18
Current Ratio1.58
Debt/Eq0.30
EPS (ttm)$3.72
EPS this Y-51.3%
EPS past 3/5Y-1.6%
Sales past 3/5Y0.5%
EPS Y/Y TTM-51.3%
Sales Y/Y TTM5.7%
Shs Outstand1.74B
ROA7.5%
ROE12.4%
ROIC10.3%
Gross Margin
Oper. Margin18.2%
Profit Margin14.7%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$43.1B
2021
$43.7B
2022
$40.1B
2023
$42.0B
2024
$44.3B
2025

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it
USDFY2021FY2022FY2023FY2024FY2025

Deep dive

Computed from the SEC EDGAR multi-year statements

Operating leverage — margins

GrossOperatingNet
0%40%80%18%15%FY21FY22FY23FY24FY25

FY25 cash-flow waterfall

Capital-light: capex is $2.2B against $9.6B operating cash
$9.6BOperating CF$2.2B− Capex$7.4BFree CF
COMMUNITY · $ABT0 theses
POST YOUR TAKE →

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.